Browsing publications by Dr Anastasia Hepburn

Newcastle AuthorsTitleYear
Dr Mohammad Moad
Dr Deepali Pal
Dr Anastasia Hepburn
Dr Stuart Williamson
Laura Wilson
et al.
A novel model of urinary tract differentiation, tissue regeneration and disease: Reprogramming of human prostate and bladder cells into induced pluripotent stem cells2013
Dr Stuart Williamson
Dr Anastasia Hepburn
Laura Wilson
Dr Kelly Coffey
Claudia Ryan-Munden
et al.
Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor2012
Dr Anastasia Hepburn
Dr Stuart Williamson
Dr Amira El-Sherif
Dr Neha Sahay
Huw Thomas
et al.
Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling2012
Dr John Blackwood
Dr Stuart Williamson
Dr Laura Greaves
Laura Wilson
Dr Anastasia Hepburn
et al.
In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells.2011
Dr Stuart Williamson
Dr Anastasia Hepburn
Professor Craig Robson
Dr Rakesh Heer
An update on the prostate cancer stem cell model-CD133+ve stem cell enriched human prostate cells express active androgen receptor2011
Dr Deepali Pal
Dr Stuart Williamson
Professor Craig Robson
Dr Anastasia Hepburn
Dr Rakesh Heer
et al.
Characterising potential for pluripotency induction in human prostate tissue2011
Dr Stuart Williamson
Dr Anastasia Hepburn
Professor Craig Robson
Dr Rakesh Heer
Comparative meta-analysis of the human prostate stem cell transcriptome demonstrates that progenitor cells are the site of malignant transformation2011
Dr Anastasia Hepburn
Dr Stuart Williamson
Professor Craig Robson
Dr Rakesh Heer
Side population in human bladder cancer enriches for cancer stem cells that can be targeted by MAPK inhibition2011
Dr Rakesh Heer
Dr Anastasia Hepburn
Dr Timothy Cheek
Professor Robert Pickard
Professor Hing Leung
et al.
Phenotypic Modulation of Human Urinary Tract Stroma-derived Fibroblasts by Transforming Growth Factor beta 32010
Dr Anastasia Hepburn
Professor Craig Robson
Professor Nicola Curtin
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer2007
12